Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Diseases

Explore clinical trials studying Neuromuscular Diseases. Study availability and eligibility vary by location and protocol.

7,118 public trials 1,300 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Diseases trial results

Recruiting

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

NCT06626919

Conditions
Autoimmune, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +19 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford Hospital Palo Alto, California, United States
  • University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

NCT06847282

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +6 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Recruiting

Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)

NCT05577754

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CHRU Brest Brest, France
  • HCL - Groupement Hospitalier Est Hôpital Femme-Mère-Enfant Bron, France
View all 13 locations
View Trial Details
Recruiting

Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma

NCT06657157

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +6 more
Locations
  • Department of Urology, University Hosptial Augsburg Augsburg, Bavaria, Germany
  • Department of Urology, LMU University Hospital, Ludwig-Maximilians-University Munich Munich, Bavaria, Germany
  • Department of Urology, Klinikum rechts der Isar, Technical University Munich Munich, Bavaria, Germany
  • Department of Urology, University Hospital of Würzburg Würzburg, Bavaria, Germany
View Trial Details

Related conditions